BridgeMD
Tests treatment safety and results for Periodontitis
Official title Effectiveness of Adjunctive Therapy of Emdogain®FL in Non-surgical Periodontal Treatment
ClinicalTrials.gov ID: NCT06070181
What this study is testing
- What it's testing
- The goal of this clinical trial is to assess the safety and effectiveness of adjunctive Emdogain® therapy in non-surgical periodontal treatment for patients with stage 3 and 4 periodontitis. The main questions it aims to answer are: Will adjunctive treatment with Emdogain® result in a greater reduction in Bleeding on Probing and probing pocket depth compared to non-surgical periodontal treatment alone?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Study Population The study population will consist of patients affected by Stage 3 or 4 periodontitis. See below for a full list of inclusion and
You likely can't join if
- . Inclusion Criteria Patients must meet all of the following criteria for inclusion in the study:
- Over 18 years old
- Stage 3 or 4 periodontitis
- Residual pockets with probing depths from 5mm to 9mm with no furcation involvement and adequate plaque control Exclusion Criteria: Patients who meet...
- Antibiotic treatment in last 3 months
- Subgingival scaling and root planning performed in last 12 months
See the full eligibility criteria
- Study Population The study population will consist of patients affected by Stage 3 or 4 periodontitis. See below for a full list of inclusion and
- . Inclusion Criteria Patients must meet all of the following criteria for inclusion in the study:
- Over 18 years old
- Stage 3 or 4 periodontitis
- Residual pockets with probing depths from 5mm to 9mm with no furcation involvement and adequate plaque control Exclusion Criteria: Patients who meet any of the following exclusion criteria are not allowed to be included...
- Antibiotic treatment in last 3 months
- Subgingival scaling and root planning performed in last 12 months
- Patients for which the use of Emdogain® is contraindicated i. e. patients with uncontrolled diabetes or other uncontrolled systemic diseases, disorders or treatments that compromise wound healing, chronic high dose...
The study team makes the final eligibility decision.
Where it's taking place
- Linköping, Region Östergötland, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Linköping, Region Östergötland, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.